Silverarc Capital Management »

Schrodinger shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Schrodinger (SDGR) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Schrodinger

Tip: Access up to 7 years of quarterly data

All positions including Schrodinger held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Schrodinger by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $857k 30k 28.27
2023-06-30 $14M 286k 49.92
2023-03-31 $5.6M 213k 26.33
2022-12-31 $2.0M 108k 18.69

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Schrodinger

BlackRock
Bill & Melinda Gates Foundation Trust
Vanguard Group
Baillie Gifford & Co
ARK Investment Management
Sumitomo Mitsui Trust Holdings
Credit Suisse
Nikko Asset Management Americas
Lazard Asset Management
Dimensional Fund Advisors
Rubric Capital Management
Tocqueville Asset Management
Fred Alger Management
T. Rowe Price Associates
Pertento Partners

View all funds holding Schrodinger